Skip to main content
SpringerLink
Log in

α-Tocopherol in Atherogenesis: Do we Know its Real Role?

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-1035.

    Google Scholar 

  2. Iribarren C, Folsom A, Jacobs DR, et al. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. Arterioscler Thromb Vasc Biol 1997;17:1171-1177.

    Google Scholar 

  3. Stephens NG, Parsons A, Schofield PM, et al. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-786.

    Google Scholar 

  4. Keaney JF, Gaziano JM, Xu A, et al. Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest 1994;93:844-851.

    Google Scholar 

  5. Baoutina A, Dean RT, Jessup W. α-Tocopherol supplementation of macrophages does not influence their ability to oxidize LDL. J Lipid Res 1998;39:114-130.

    Google Scholar 

  6. Witting PK, Bowry VW, Stocker R. Inverse deuterium kinetic isotope effect for peroxidation in human low-density lipoprotein (LDL): A simple test for tocopherol-mediated peroxidation of LDL lipids. FEBS Lett 1995;375:45-49.

    Google Scholar 

  7. Kontush A, Finck B, Karten B, Kohlschütter A, Beisiegel U. Antioxidant and prooxidant activity of a-tocopherol in human plasma and low density lipoprotein. J Lipid Res 1996;37:1436-1448.

    Google Scholar 

  8. Neuzil J, Thomas SR, Stocker R. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic Biol Med 1997;22:57-71.

    Google Scholar 

  9. Kleinveld HA, Hak-Lemmers HLM, Hectors MOC, de Fouw NJ, Demacker PNM, Stalenhoef AFH. Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 1995;15:290-297.

    Google Scholar 

  10. Parker RA, Sabrah T, Cap M, Gill BT. Relation of vascular oxidative stress, α-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arterioscler Thromb Vasc Biol 1995;15:349-358.

    Google Scholar 

  11. Fruebis J, Bird DA, Pattison J, Palinski W. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. J Lipid Res 1997;38: 2455-2464.

    Google Scholar 

  12. Bowry VW, Stocker R. Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 1993;115:6029-6044.

    Google Scholar 

  13. Thomas SR, Neuzil J, Stocker R. Co-supplementation with coenzyme Q prevents the prooxidant effect of α-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation. Arterioscler Thromb Vasc Biol 1996;16:687-96.

    Google Scholar 

  14. Upston JM, Neuzil J, Stocker R. Oxidation of LDL by recombinant human 15-lipoxygenase: Evidence for α-tocopherol-dependent oxidation of esterified core and surface lipids. J Lipid Res 1996;37:2650-2661.

    Google Scholar 

  15. Kontush A, Meyer S, Finck B, Kohlschütter A, Beisiegel U. α-Tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation. J Biol Chem 1996;271:11106-11112.

    Google Scholar 

  16. Bowry VW, Mohr D, Cleary J, Stocker R. Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J Biol Chem 1995;270: 5756-5763.

    Google Scholar 

  17. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 1994;269:16712-16719.

    Google Scholar 

  18. Witting PK, Westerlund C, Stocker R. A rapid and simple screening test for potential inhibitors of tocopherol-mediated peroxidation of LDL lipids. J Lipid Res 1996;37:853-867.

    Google Scholar 

  19. Neuzil J, Witting PK, Stocker R. α-Tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein. Proc Natl Acad Sci USA 1997;96:7885-7890.

    Google Scholar 

  20. Dabbagh AJ, Frei B. Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems. J Clin Invest 1995;96:1958-1966.

    Google Scholar 

  21. Neuzil J, Darlow BA, Inder TE, Sluis KB, Winterbourn CC, Stocker R. Oxidation of parenteral lipid emulsion by ambient and phototherapy lights: Potential toxicity of routine parenteral feeding. J Pediatr 1995;126:185-190.

    Google Scholar 

  22. Suarna C, Dean R, May J, Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol 1995;15:1616-1624.

    Google Scholar 

  23. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-353.

    Google Scholar 

  24. Neuzil J, Christison JK, Iheanacho E, et al. Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE-/-) mice: apoE-/- mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis. J Lipid Res 1998;39:354-368.

    Google Scholar 

  25. Tangirala RK, Casanada F, Miller E, Witztum JL, Steinberg D, Palinski W. Effect of the antioxidant N,N′-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice. Arterioscler Thromb Vasc Biol 1995; 15:1625-1630.

    Google Scholar 

  26. Kühn H, Belkner J, Zaiss S, Fahrenklemper T, Wohlfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J Exp Med 1994;179:1903-1911.

    Google Scholar 

  27. Upston JM, Neuzil J, Witting PK, Alleva R, Stocker R. Oxidation of free fatty acids in low density lipoprotein by 15-lipoxygenase stimulates nonenzymic, α-tocopherol-mediated peroxidation of cholesteryl esters. J Biol Chem 1997; 272:30067-30074.

    Google Scholar 

  28. Neuzil J, Upston JM, Witting PK, Scott K, Stocker R. Secretory phospholipase A2 and lipoprotein lipase enhance 15-lipoxygenase-induced enzymic and non-enzymic lipid peroxidation in low-density lipoprotein lipids. Biochemistry 1998;37:9203-9290.

    Google Scholar 

  29. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-720.

    Google Scholar 

  30. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J 1997;11:118-224.

    Google Scholar 

  31. Deveraj S, Jialal I. The effect of alpha-tocopherol on critical cells in atherogenesis. Curr Opin Lipidol 1998;9:11-15.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Prevention of Cardiovascular Diseases, Ludwig Maximilians University, Munich, Germany

    Jiri Neuzil & Anna Baoutina

  2. Cell Biology Group, Heart Research Institute, Sydney, Australia

    Jiri Neuzil & Anna Baoutina

Authors
  1. Jiri Neuzil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Baoutina
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neuzil, J., Baoutina, A. α-Tocopherol in Atherogenesis: Do we Know its Real Role?. Cardiovasc Drugs Ther 12, 421–423 (1998). https://doi.org/10.1023/A:1007782012646

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007782012646

Search

Navigation